| Phase 01 trial |
|
Phase 0
|
NCT04663126 |
Feb 2021 → Jan 2023 |
melanoma |
John O. Prior |
Terminated
|
No outcome recorded
|
| Phase 14 trials |
|
Phase 1
|
NCT03332940 |
Dec 2017 → Mar 2019 |
metabolic dysfunction-associated steatohepatitis |
Navidea Biopharmaceuticals |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT03241446 |
Sep 2017 → Jan 2018 |
rheumatoid arthritis |
Navidea Biopharmaceuticals |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT03029988 |
Jul 2017 → Sep 2018 |
colorectal carcinoma, metastasis from malignant tumor of colon |
Navidea Biopharmaceuticals |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT02683421 |
Jul → Dec 2016 |
rheumatoid arthritis |
Navidea Biopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase 1/21 trial |
|
Phase 1/2
|
NCT02865434 |
Jan 2017 → Jun 2018 |
rheumatoid arthritis |
Navidea Biopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase 22 trials |
|
Phase 2
|
NCT04078191 |
Sep 2021 → Jul 2024 |
rheumatoid arthritis |
Navidea Biopharmaceuticals |
Terminated
|
No outcome recorded
Stop: Business |
|
Phase 2
|
NCT02201420 |
Sep 2014 → Mar 2015 |
Kaposi's sarcoma |
Navidea Biopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT05246280 |
Mar 2022 → Jul 2024 |
rheumatoid arthritis |
Navidea Biopharmaceuticals |
Terminated
|
No outcome recorded
Stop: Business |
| Comparator or background therapy2 trials |
|
Phase 4
|
NCT04487912 Comparator |
Nov 2020 → May 2021 |
breast cancer |
University Hospital, Ghent |
Withdrawn
|
No outcome recorded
|
|
Phase 4
|
NCT03199560 Comparator |
Jun 2017 → Jun 2019 |
breast cancer |
Memorial Health University Medical Center |
Unknown
|
No outcome recorded
|